Group One Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-127
Closed -$46K 5730
2018
Q2
$46K Buy
127
+57
+81% +$26.8K ﹤0.01% 4000
2018
Q1
$32K Buy
+70
New +$34.8K ﹤0.01% 3882
2016
Q4
Sell
-29
Closed -$27K 4938
2016
Q3
$27K Buy
+29
New +$36.6K ﹤0.01% 3672
2016
Q2
Sell
-1
Closed -$1K 5027
2016
Q1
$1K Hold
1
﹤0.01% 4463
2015
Q4
$1K Sell
1
-4
-80% -$5.22K ﹤0.01% 4631
2015
Q3
$8K Sell
5
-2
-29% -$3.86K ﹤0.01% 4379
2015
Q2
$15K Buy
+7
New +$22K ﹤0.01% 4166
2015
Q1
Hold
0
4657
2014
Q4
Sell
-5
Closed -$18K 5372
2014
Q3
$18K Hold
5
﹤0.01% 4174
2014
Q2
$21K Buy
5
+4
+400% +$15.1K ﹤0.01% 4133
2014
Q1
$4K Sell
1
-7
-88% -$31.3K ﹤0.01% 4879
2013
Q4
$30K Sell
8
-57
-88% -$216K ﹤0.01% 4010
2013
Q3
$255K Buy
65
+61
+1,525% +$458K ﹤0.01% 2170
2013
Q2
$40K Buy
+4
New +$44.3K ﹤0.01% 3625

Other funds holding FRTX

Group One Trading's FRTX Position: Q2 2018 in Review

Group One Trading held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q2 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5578.

Group One Trading first reported a position in FRTX in Q3 2013 and has held it in 13 quarters since. The position peaked at $70K in Q3 2013. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2018.

  • Group One Trading held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q2 2018.
  • Group One Trading left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q2 2018.
  • Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Group One Trading's portfolio in Q2 2018, its #5578 holding.
  • Group One Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and has held it in 13 quarters since.
  • Group One Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $70K in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.